Digenic parkinsonism:: Investigation of the synergistic effects of PRKN and LRRK2

被引:45
作者
Dachsel, Justus C.
Mata, Ignacio F.
Ross, Owen A. [1 ]
Taylor, Julie P.
Lincoln, Sarah J.
Hinkle, Kelly M.
Huerta, Cecilia
Ribacoba, Renee
Blazquez, Marta
Alvarez, Victoria
Farrer, Matthew J.
机构
[1] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL USA
[2] Hosp Univ Cent Asturias, IRSINFRIAT, Inst Invest Nefrol, Mol Genet Lab, Oviedo, Spain
[3] Hosp Univ Cent Asturias, Neurol Serv, Oviedo, Spain
[4] Hosp Alvarez Buylla, Neurol Serv, Mieres, Spain
关键词
parkin; LRRK2; gene; protein interaction;
D O I
10.1016/j.neulet.2006.06.068
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
The complex genetic etiology of Parkinson's disease (PD) is indicative of a multifactorial syndrome. A combination of gene-gene and gene-environment interactions may determine a variable phenotypic outcome. Recently a direct gene/protein interaction between two of the most common genetic causes of parkinsonism PRKN and LRRK2 has been postulated. We have identified three Spanish patients simultaneously harboring mutations in PRKN and LRRK2. In comparison to other Spanish patients with a single LRRK2 or PRKN mutation, the three doublemutation patients reported here do not present with an earlier age-at-onset or a faster progression of disease. Although the clinical findings do not support a synergistic effect of LRRK2 and PRKN, a potential genetic interplay might be concealed by the modulating effects of other genes. Nevertheless, this work demonstrates that the presence of mutations in one familial gene should not serve as exclusion criteria in a screen for further genetic variation. Direct interaction of Lrrk2 and parkin proteins was not observed in co-immunoprecipitation pull down experiments. However, in vivo studies are required to assess whether there is an indirect link between Lrrk2 and parkin in disease pathogenesis. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:80 / 84
页数:5
相关论文
共 20 条
[1]
The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration [J].
Corti, O ;
Hampe, C ;
Koutnikova, H ;
Darios, F ;
Jacquier, S ;
Prigent, A ;
Robinson, JC ;
Pradier, L ;
Ruberg, M ;
Mirande, M ;
Hirsch, E ;
Rooney, T ;
Fournier, A ;
Brice, A .
HUMAN MOLECULAR GENETICS, 2003, 12 (12) :1427-1437
[2]
Genetics of Parkinson disease: paradigm shifts and future prospects [J].
Farrer, MJ .
NATURE REVIEWS GENETICS, 2006, 7 (04) :306-318
[3]
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease [J].
Foroud, T ;
Uniacke, SK ;
Liu, L ;
Pankratz, N ;
Rudolph, A ;
Halter, C ;
Shults, C ;
Marder, K ;
Conneally, PM ;
Nichols, WC .
NEUROLOGY, 2003, 60 (05) :796-801
[4]
Diagnostic criteria for Parkinson disease [J].
Gelb, DJ ;
Oliver, E ;
Gilman, S .
ARCHIVES OF NEUROLOGY, 1999, 56 (01) :33-39
[5]
Initiation and synergistic fibrillization of tau and alpha-synuclein [J].
Giasson, BI ;
Forman, MS ;
Higuchi, M ;
Golbe, LI ;
Graves, CL ;
Kotzbauer, PT ;
Trojanowski, JQ ;
Lee, VMY .
SCIENCE, 2003, 300 (5619) :636-640
[6]
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity [J].
Gloeckner, CJ ;
Kinkl, N ;
Schumacher, A ;
Braun, RJ ;
O'Neill, E ;
Meitinger, T ;
Kolch, W ;
Prokisch, H ;
Ueffing, M .
HUMAN MOLECULAR GENETICS, 2006, 15 (02) :223-232
[7]
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor -: art. no. e65 [J].
Goldwurm, S ;
Di Fonzo, A ;
Simons, EJ ;
Rohé, CF ;
Zini, M ;
Canesi, M ;
Tesei, S ;
Zecchinelli, A ;
Antonini, A ;
Mariani, C ;
Meucci, N ;
Sacilotto, G ;
Sironi, F ;
Salani, G ;
Ferreira, J ;
Chien, HF ;
Fabrizio, E ;
Vanacore, N ;
Dalla Libera, A ;
Stocchi, F ;
Diroma, C ;
Lamberti, P ;
Sampaio, C ;
Meco, G ;
Barbosa, E ;
Bertoli-Avella, AM ;
Breedveld, GJ ;
Oostra, BA ;
Pezzoli, G ;
Bonifati, V .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (11) :e65
[8]
Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations [J].
Ishihara, Lianna ;
Warren, Liling ;
Gibson, Rachel ;
Amouri, Rim ;
Lesage, Suzanne ;
Durr, Alexandra ;
Tazir, Meriem ;
Wszolek, Zbigniew K. ;
Uitti, Ryan J. ;
Nichols, William C. ;
Griffith, Alida ;
Hattori, Nobutaka ;
Leppert, David ;
Watts, Ray ;
Zabetian, Cyrus P. ;
Foroud, Tatiana M. ;
Farrer, Matthew J. ;
Brice, Alexis ;
Middleton, Lefkos ;
Hentati, Faycal .
ARCHIVES OF NEUROLOGY, 2006, 63 (09) :1250-1254
[9]
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations [J].
Kachergus, J ;
Mata, IF ;
Hulihan, M ;
Taylor, JP ;
Lincoln, S ;
Aasly, J ;
Gibson, JM ;
Ross, OA ;
Lynch, T ;
Wiley, J ;
Payami, H ;
Nutt, J ;
Maraganore, DM ;
Czyzewski, K ;
Styczynska, M ;
Wszolek, ZK ;
Farrer, MJ ;
Toft, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (04) :672-680
[10]
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs [J].
Lesage, S ;
Dürr, A ;
Tazir, M ;
Lohmann, E ;
Leutenegger, AL ;
Janin, S ;
Pollak, P ;
Brice, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) :422-423